Broad Catalog of Research Compounds At launch, OMNI Peptides offers a growing selection of research materials that includes BPC-157, GHK-Cu, KPV, MOTS-C, NAD+, Semaglutide, Tirzepatide, Tesamorelin, CJC-1295 with Ipamorelin, 5-Amino-1MQ and additional compounds intended exclusively for controlled laboratory investigation
Compounded BPC-157 from a licensed pharmacy is tested for sterility, potency, and the absence of contaminants
Adequate levels support normal energy metabolism, which may help reduce fatigue related to deficiency
While BPC-157 shows no strong evidence of tolerance or receptor desensitization in most reports (unlike some growth hormone-releasing peptides), cycling is still utilized for safety, sustainability, and optimization
Legal status (US): BPC-157 has no FDA-approved indication